Robert J. Bitterman - Jun 30, 2023 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
President & CEO, Director
Signature
Caitlin Kontulis, attorney-in-fact
Stock symbol
PHIO
Transactions as of
Jun 30, 2023
Transactions value $
$5,720
Form type
4
Date filed
7/5/2023, 06:00 PM
Previous filing
Feb 22, 2023
Next filing
Oct 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Purchase $2.88K +1K +5.81% $2.88 18.2K Jun 30, 2023 Direct F1
transaction PHIO Common stock, $0.0001 par value Purchase $2.84K +1K +5.49% $2.84 19.2K Jul 1, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of common stock underlying unvested restricted stock units.